Joseph P Lyssikatos

Chief Scientific Officer, Enliven Therapeutics, Inc.

Bought, 12 months

$0.0M

Sold, 12 months

$4.5M

Companies

Latest trade

Feb 6, 2026

Companies

Enliven Therapeutics, Inc.Chief Scientific Officer −$4.8M

Trades

ELVN Sold 5,000 shares at $29.04 · planned $0.1M Feb 6

ELVN Sold 20,000 shares at $26.75 · planned $0.5M Jan 20

ELVN Sold 91,198 shares at $27.22 · planned $2.5M Jan 9

ELVN Sold 41,302 shares at $24.05 · planned $1.0M Jan 8

ELVN Sold 5,000 shares at $16.84 · planned $0.1M Dec 19

ELVN Sold 12,500 shares at $22.33 · planned $0.3M Nov 19

ELVN Sold 12,500 shares at $22.08 · planned $0.3M Oct 20

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.